PHARMA MAR, S.A. «...678910...» Page 6 out of 23 05/12/2023 17:38 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The Company reports on treasury share acquisitions in the period from November 1 to November 30, 2023. Register number: 25709 04/12/2023 08:31 PHARMA MAR, S.A. On business and financial situation The Company announces that its partner Luye Pharma Group Ltd has received approval for commercialization for Zepzelca® (lurbinectedina) in Macao. Register number: 25626 07/11/2023 08:26 PHARMA MAR, S.A. On business and financial situation The Company announces that its partner Adium Pharma has received approval for commercialization for Zepzelca® (lurbinectedina) in Peru. Register number: 25260 06/11/2023 17:37 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The Company reports on treasury share acquisitions in the period from October 1 to October 31, 2023 Register number: 25251 06/11/2023 08:26 PHARMA MAR, S.A. On business and financial situation The Company announces a US$10 million milestone payment from Janssen Products LP Register number: 25247 31/10/2023 08:28 PHARMA MAR, S.A. On business and financial situation Pharma Mar initiates a Phase IIb/III clinical trial of Zepzelca® (lurbinectedin) for the treatment of patients with metastatic Leiomyosarcoma Register number: 25154 26/10/2023 17:38 PHARMA MAR, S.A. Other relevant information - On business and financial situation The Company files third quarter 2023 financial information and announces a conference call with analysts and investors. Register number: 25054 04/10/2023 18:37 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The Company reports on treasury share acquisitions in the period from September 1 to September 30, 2023. Register number: 24759 04/10/2023 17:39 PHARMA MAR, S.A. Liquidity and counterparty agreements The Company reports details of the operations of the Liquidity Agreement during third quarter of the year 2023 Register number: 24757 06/09/2023 17:41 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The Company reports on treasury share acquisitions in the period from August 1 to August 31, 2023. Register number: 24365 Page 6 out of 23 «...678910...»
